Abbasi NR, Yancovitz M, Gutkowicz-Krusin D, Panageas KS, Mihm MC, Googe P, King R, Prieto V, Osman I, Friedman RJ, Rigel DS, Kopf AW, Polsky D. Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. Archives of Dermatology .
Abu-Rustum NR, Iasonos A, Zhou Q, Oke E, Soslow RA, Alektiar KM, Chi DS, Barakat RR.. Is there a therapeutic benefit to regional lymphadenectomy in the surgical treatment of endometrial cancer? American Journal of Obstetrics and Gynecology .
Al-Ahmadie HA, Alden D, Qin LX, Olgac S, Fine SW, Gopalan A, Russo P, Motzer RJ, Reuter VE, Tickoo SK. Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing two antibodies. American Journal of Surgical Pathology .
BrintzenhofeSzoc KM, Levin TT, Li Y, Zabora J. The prevalence of mixed anxiety-depression by cancer type. Psychosomatics 2007; .
Cho NL, Redson M, Zauber AG, Carothers AM, Hornick J, Wilton A, Sontag S, Nishioka N, Giardiello F, Saltzman JR, Gostout C, Eagle CJ, Hawk ET, Bertagnolli MM. Aberrant crypt foci I(AXF) are not surrogate biomarkers of sporadic adenoma prevention with celecoxib: results from the adenoma prevention with celecoxib (APC) trial. Cancer Research Prevention .
Dang C, Fornier M, Sugarman S, Troso-Sandoval T, Lake D, D'Andrea G, Seidman A, Sklarin N, Dickler M, Currie V, Gilewski T, Moynahan ME, Drullinsky P, Robson M, Wasserheit-Leiblich C, Mills N, Steingart R, Panageas K, Norton L, Hudis C. Dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER2/neu verexpressed/amplified breast cancer is feasible. Journal of Clinical Oncology .
Figueiredo JC, Bernstein L, Capanu M, Malone KE, Lynch CF, Haile RW, the WECARE Study Collaborative Group, Bernstein JL. Oral contraceptives, post-menopausal hormones and risk of asynchronous bilateral breast cancer: the WECARE study group. Journal of Clinical Oncology .
Fornier M, Rathkopf D, Shah M, Patil SM, O'Reilly E, Tse A, Hudis C, Kelsen DP, Schwartz L. Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors, CCR-07-1218 Version 2. Clinical Cancer Research .
Forslund A, Zeng A, Qin LX, Rosenberg S, Ndubuisi M, Pincas H, Gerald W, Notterman D, Barany F, Paty PB. MDM2 gene amplification is correlated to tumor progression but not to presence of SNP309 or TP53 mutational status in primary colorectal cancers. Molecular Cancer Research .
Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. Journal of Clinical Oncology .
King V, Ginsberg MS, Vaze AA, Moskowitz CS, Smith LJ. Utility of the d-dimer assay for the exclusion of pulmonary embolism in a high risk oncologic population: a correlation with CT pulmonary angiogram in the urgent care setting. Radiology .
Klimek VM, Fircanis S, Maslak P, Guernah I, Baum M, Wu N, Panageas K, Wright JJ, Pandolfi PP, Nimer SD. Tolerability, pharmacodynamics and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes. Clinical Cancer Research .
Mellemkjær L, Dahl C, Olsen JH, Bertelsen L, Guldberg P, Christensen J, Børresen-Dale A-L, Stovall M, Langholz B, Bernstein L, Lynch CF, Malone KE, Haile RW, Andersson M, Thomas DC, Concannon P, Capanu M, Boice JD, the WECARE Study Collaborative Group, Bernstein JL. Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study. British Journal of Cancer .
Moskowitz CS, Seshan VE, Riedel ER, Begg CB. Estimating the empirical Lorenz curve and Gini coefficient in the presence of error with nested data. Statistics in Medicine
Orlow I, Park BJ, Mujumdar U, Patel H, Siu-Lau P, Clas BA, Downey R, Flores R, Bains M, Rizk N, Dominguez G, Jani J, Berwick M, Begg CB, Kris MG, Rusch VW. DNA damage and repair capacity in lung cancer patients: prediction of multiple primary tumors. Journal of Clinical Oncology
Raizer JJ, Hwu W-J, Panageas KS, Wilton A, Baldwin DE, Bailey E, Von Althann C, Lamb LA, Alvarado G, Bilsky MH, Gutin PH. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features from neuro-oncology. Neuro-oncology .
Rietschel P, Wolchok JD, Krown S, Gerst S, Jungbluth A, Busam K, Smith K, Orlow I, Panageas K, Chapman PB. Phase II study of extended dose temozolomide in patients with melanoma. Journal of Clinical Oncology .
Roohipour R, Patil SM, Goodman KA, Minsky B, Wong WD, Guillem JG, Paty PB, Weiser MR, Neuman HB, Shia J, Schrag D, Temple LKF. Squamous cell carcinoma of the anal canal: predictors of treatment outcome. Diseases of the Colon and Rectum .
Shen R, Ghosh D, Taylor JMG. Modeling intra-tumor protein expression heterogeneity in tissue microarray experiments. Statistics in Medicine .
Steinberg AG, Bain L, Ewing R, Li Y. Meeting the public's health information needs: a plain language website outreach project: to reaching underserved parents of deaf children. Health Communication .
Tan LK, Giri DD, Hummer AJ, Panageas KS, Brogi E, Norton L, Hudis C, Borgen PI, Cody HS. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. Journal of Clinical Oncology .
Traina TA, Theodoulou M, Feigin F, Patil SM, Tan KL, Edwards C, Dugan U, Norton L, Hudis C. Phase I study of a novel capecitabine schedule based upon the Norton-Simon mathematical model in patients with metastatic breast cancer. Journal of Clinical Oncology .
Zauber AG, Levin TR, Jaffe CC, Galen BA, Ransohoff DR, Brown ML. Implications of new colorectal cancer screening technologies for primary care practice. Medical Care .
